209 related articles for article (PubMed ID: 22387083)
21. A favorable solubility partner for the recombinant expression of streptavidin.
Sørensen HP; Sperling-Petersen HU; Mortensen KK
Protein Expr Purif; 2003 Dec; 32(2):252-9. PubMed ID: 14965771
[TBL] [Abstract][Full Text] [Related]
22. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
[TBL] [Abstract][Full Text] [Related]
23. The novel Fh8 and H fusion partners for soluble protein expression in Escherichia coli: a comparison with the traditional gene fusion technology.
Costa SJ; Almeida A; Castro A; Domingues L; Besir H
Appl Microbiol Biotechnol; 2013 Aug; 97(15):6779-91. PubMed ID: 23160981
[TBL] [Abstract][Full Text] [Related]
24. Production of soluble human interleukin-6 in cytoplasm by fed-batch culture of recombinant E. coli.
Kim TW; Chung BH; Chang YK
Biotechnol Prog; 2005; 21(2):524-31. PubMed ID: 15801793
[TBL] [Abstract][Full Text] [Related]
25. Expression and characterization of a functional single-chain variable fragment (scFv) protein recognizing MCF7 breast cancer cells in E. coli cytoplasm.
Mahgoub IO
Biochem Genet; 2012 Aug; 50(7-8):625-41. PubMed ID: 22552770
[TBL] [Abstract][Full Text] [Related]
26. Anti-glycophorin single-chain Fv fusion to low-affinity mutant erythropoietin improves red blood cell-lineage specificity.
Taylor ND; Way JC; Silver PA; Cironi P
Protein Eng Des Sel; 2010 Apr; 23(4):251-60. PubMed ID: 20083493
[TBL] [Abstract][Full Text] [Related]
27. Production of single chain fragment variable (scFv) antibodies in Escherichia coli using the LEX™ bioreactor.
Miethe S; Meyer T; Wöhl-Bruhn S; Frenzel A; Schirrmann T; Dübel S; Hust M
J Biotechnol; 2013 Jan; 163(2):105-11. PubMed ID: 22902410
[TBL] [Abstract][Full Text] [Related]
28. Enhancing recombinant protein solubility with ubiquitin-like small archeal modifying protein fusion partners.
Varga S; Pathare GR; Baka E; Boicu M; Kriszt B; Székács A; Zinzula L; Kukolya J; Nagy I
J Microbiol Methods; 2015 Nov; 118():113-22. PubMed ID: 26341610
[TBL] [Abstract][Full Text] [Related]
29. A universal strategy for stable intracellular antibodies.
Shaki-Loewenstein S; Zfania R; Hyland S; Wels WS; Benhar I
J Immunol Methods; 2005 Aug; 303(1-2):19-39. PubMed ID: 16045924
[TBL] [Abstract][Full Text] [Related]
30. Generation of AcGFP fusion with single-chain Fv selected from a phage display library constructed from mice hyperimmunized against 5-methyl 2'-deoxycytidine.
Ohshima M; Inoue K; Hayashi H; Tsuji D; Mizugaki M; Itoh K
Protein Eng Des Sel; 2010 Nov; 23(11):881-8. PubMed ID: 20876190
[TBL] [Abstract][Full Text] [Related]
31. HaloTag7: a genetically engineered tag that enhances bacterial expression of soluble proteins and improves protein purification.
Ohana RF; Encell LP; Zhao K; Simpson D; Slater MR; Urh M; Wood KV
Protein Expr Purif; 2009 Nov; 68(1):110-20. PubMed ID: 19464373
[TBL] [Abstract][Full Text] [Related]
32. A fast mutagenesis procedure to recover soluble and functional scFvs containing amber stop codons from synthetic and semisynthetic antibody libraries.
Barderas R; Shochat S; Martínez-Torrecuadrada J; Altschuh D; Meloen R; Ignacio Casal J
J Immunol Methods; 2006 May; 312(1-2):182-9. PubMed ID: 16674972
[TBL] [Abstract][Full Text] [Related]
33. Expression and secretion of a CB4-1 scFv-GFP fusion protein by fission yeast.
Naumann JM; Küttner G; Bureik M
Appl Biochem Biotechnol; 2011 Jan; 163(1):80-9. PubMed ID: 20617397
[TBL] [Abstract][Full Text] [Related]
34. New fusion protein systems designed to give soluble expression in Escherichia coli.
Davis GD; Elisee C; Newham DM; Harrison RG
Biotechnol Bioeng; 1999 Nov; 65(4):382-8. PubMed ID: 10506413
[TBL] [Abstract][Full Text] [Related]
35. Soluble expression, purification, and characterization of Gloydius shedaoensis venom gloshedobin in Escherichia coli by using fusion partners.
Jiang X; Xu J; Yang Q
Appl Microbiol Biotechnol; 2010 Jan; 85(3):635-42. PubMed ID: 19639313
[TBL] [Abstract][Full Text] [Related]
36. High-level expression, purification, and characterization of bifunctional ScFv-9R fusion protein.
Zhang X; Xie J; Sun Y; Xu H; Du T; Liu Z; Chen J; Zheng Z; Liu K; Zhang J; Kan M; Li X; Xiao Y
Appl Microbiol Biotechnol; 2014 Jun; 98(12):5499-506. PubMed ID: 24519456
[TBL] [Abstract][Full Text] [Related]
37. Generation of scFv specific to human VEGFR-3 from the neutralizing mAb BDD073.
Chen H; Wang C; Gao Y; Gao J; Zhou X; Cai Z; Sun Q
Protein Eng Des Sel; 2015 Jan; 28(1):19-22. PubMed ID: 25428897
[TBL] [Abstract][Full Text] [Related]
38. A strategy for high-level expression of a single-chain variable fragment against TNFα by subcloning antibody variable regions from the phage display vector pCANTAB 5E into pBV220.
Yang T; Yang L; Chai W; Li R; Xie J; Niu B
Protein Expr Purif; 2011 Mar; 76(1):109-14. PubMed ID: 20951213
[TBL] [Abstract][Full Text] [Related]
39. A combinatorial approach of N-terminus blocking and codon optimization strategies to enhance the soluble expression of recombinant hIL-7 in E. coli fed-batch culture.
Devi N; Adivitiya ; Khasa YP
Appl Microbiol Biotechnol; 2016 Dec; 100(23):9979-9994. PubMed ID: 27342246
[TBL] [Abstract][Full Text] [Related]
40. Single-chain variable fragment (scFv) antibodies optimized for environmental analysis of uranium.
Zhu X; Kriegel AM; Boustany CA; Blake DA
Anal Chem; 2011 May; 83(10):3717-24. PubMed ID: 21473651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
